Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy

Table 1

Marketed nanosystems for cancer treatment.

Product name	Drug	Type of nanocarrier	Company
Daunoxome	Daunorubicin citrate	Liposome	Gilead Science, Cambridge, UK
Doxil	Doxorubicin HCl	Liposome	Johnson and Johnson, NJ, USA
Myocet	Doxorubicin	Liposome	Sopherion Therapeutics, NJ, USA
Caelyx	Doxorubicin HCl	Pegylated liposome	Johnson and Johnson, NJ, USA
Transdrug	Doxorubicin	Poly(alkylcyanoacrylate) nanoparticles	BioAlliance, Paris, France
Genexol-PM	Paclitaxel	Methoxy-PEG-polylactide nanoparticles	Samyang, South Korea
Oncaspar	Pegaspargase	PEG-asparaginase nanoparticles	Enzon, NJ, USA
Abraxane	Paclitaxel	Albumin-bound nanoparticles	American Bioscience, CA, USA